FRS2 - fibroblast growth factor receptor substrate 2 Gene
Also Known as SNT; SNT1; FRS1A; FRS2A; SNT-1; FRS2alpha
Species: Homo sapiens
About FRS2
This gene has 11 transcripts (splice variants), 230 orthologues and 7 paralogues. Ubiquitous expression in thyroid (RPKM 6.6), endometrium (RPKM 6.6) and 25 other tissues.
Summary
Enables Fibroblast Growth Factor receptor binding activity and neurotrophin TrkA receptor binding activity. Involved in negative regulation of cardiac muscle cell differentiation. Acts upstream of or within Fibroblast Growth Factor receptor signaling pathway. Located in adherens junction. Biomarker of renal cell carcinoma. [provided by Alliance of Genome Resources, Apr 2022]
FRS2 Products (8)
| mRNA | Protein | Name |
|---|---|---|
| NM_001042555.3 | NP_001036020.1 | fibroblast growth factor receptor substrate 2 |
| NM_001278351.2 | NP_001265280.1 | fibroblast growth factor receptor substrate 2 |
| NM_001278353.2 | NP_001265282.1 | fibroblast growth factor receptor substrate 2 |
| NM_001278354.2 | NP_001265283.1 | fibroblast growth factor receptor substrate 2 |
| NM_001278355.2 | NP_001265284.1 | fibroblast growth factor receptor substrate 2 |
| NM_001278356.2 | NP_001265285.1 | fibroblast growth factor receptor substrate 2 |
| NM_001278357.2 | NP_001265286.1 | fibroblast growth factor receptor substrate 2 |
| NM_006654.5 | NP_006645.3 | fibroblast growth factor receptor substrate 2 |
| Molecular Function GO Annotation | Evidence | Verweise | Source |
|---|---|---|---|
| enables fibroblast growth factor receptor binding |
IPI
IPI: Inferred from physical interaction
|
9660748 | GOA |
| enables neurotrophin TRKA receptor binding |
IPI
IPI: Inferred from physical interaction
|
15488758 | GOA |
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
9632781 | GOA |
| Biological Process GO Annotation | Evidence | Verweise | Source |
|---|---|---|---|
| acts upstream of or within fibroblast growth factor receptor signaling pathway |
IGI
IGI: Inferred from genetic interaction
|
9660748 | GOA |
| involved in negative regulation of cardiac muscle cell differentiation |
IGI
IGI: Inferred from genetic interaction
|
23939491 | GOA |
| Cellular Component GO Annotation | Evidence | Verweise | Source |
|---|---|---|---|
| located in adherens junction |
IDA
IDA: Inferred from direct assay
|
25468996 | GOA |
FRS2 Protein Structure
IRS: PTB domain (IRS-1 type) (18 - 107)
- 0
- 100
- 200
- 300
- 400
- 508 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
fibroblast growth factor receptor substrate 2 |
|
FRS2 Protein-protein interaction Information
|
Type
|
Protein Name | Protein ID | Interactor | Interactor Species | Interactor ID | Detection Method | Verweise |
|---|---|---|---|---|---|---|---|
|
Intra
|
FRS2 | Q8WU20 | FGFR1 | Homo sapiens | P11362 | 21765395 | |
|
Intra
|
FRS2 | Q8WU20 | PTPN11 | Homo sapiens | Q06124 | 9632781 |
FRS2 Antibodies
| Art. -Nr. | Produktname | Anwendung | Reactivity |
|---|---|---|---|
| HY-P81655 | FRS2 Antibody (YA1400) | WB, IP | Human |
| HY-P81655A | FRS2 Antibody (YA1400)(PBS only) | WB, IP | Human |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Achondroplasia, Severe, With Developmental Delay And Acanthosis Nigricans |
|
|
| Liposarcoma |
|
|
| Beare-Stevenson Cutis Gyrata Syndrome |
|
|
| Central Nervous System Lipoma |
|
|
| Kallmann Syndrome |
|
|
| Parosteal Osteosarcoma |
|
|
| Thanatophoric Dysplasia, Type I |
|
|
| Peripheral Osteosarcoma |
|
|
| Craniosynostosis |
|
|
| Well-Differentiated Liposarcoma |
|
|
| Crouzon Syndrome |
|
|
| Pleomorphic Liposarcoma |
|
|
| Dedifferentiated Liposarcoma |
|
|
| Lacrimoauriculodentodigital Syndrome |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Rattus norvegicus | FRS2 | RGD | RGD:1308201 |
| Felis catus | FRS2 | VGNC | VGNC:84021 |
| Mus musculus | FRS2 | MGD | MGI:1100860 |
| Bos taurus | FRS2 | VGNC | VGNC:29120 |
| Macaca mulatta | FRS2 | VGNC | VGNC:72732 |
| Canis familiaris | FRS2 | VGNC | VGNC:40986 |
| Others | FRS2 | NCBI |